This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignees: National Institute of Health and Medical Research, Ose Immunotherapeutics, The University of Nantes. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 1,853 
1 out of 30 
1 out of 156 
Years Active: 2025
Title: Marion Drouin: Innovator in Immunotherapy
Introduction
Marion Drouin is a notable inventor based in Savenay, France. He has made significant contributions to the field of immunotherapy through his innovative research and development of specific antibodies.
Latest Patents
Drouin holds a patent for "Humanized anti-CLEC-1A antibodies and antigen-binding fragments thereof." This invention focuses on providing specific humanized anti-CLEC-1A antibodies and their antigen-binding fragments. The compounds developed in this patent are designed to specifically bind to the CLEC-1A receptor, antagonizing its interaction with endogenous ligands. This innovation has potential applications in treating various deleterious conditions.
Career Highlights
Throughout his career, Marion Drouin has worked with esteemed institutions such as Inserm (Institut National de la Santé et de la Recherche Médicale) and Université de Nantes. His work in these organizations has allowed him to advance his research and contribute to the scientific community.
Collaborations
Drouin has collaborated with various professionals in his field, including his coworker Sabrina Pengam. These collaborations have further enriched his research and development efforts.
Conclusion
Marion Drouin is a prominent figure in the field of immunotherapy, with a patent that showcases his innovative approach to medical treatment. His work continues to influence the development of therapeutic solutions for challenging health conditions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile